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Cocaine addiction is characterized by compulsive drug use despite adverse consequences
and high rate of relapse during periods of abstinence. Increasing consensus suggests
that addiction to drugs of abuse usurps learning and memory mechanisms normally
related to natural rewards, ultimately producing long-lasting neuroadaptations in the
mesocorticolimbic system. This system, formed in part by the ventral tegmental area
and nucleus accumbens (NAc), has a central role in the development and expression of
addictive behaviors. In addition to a broad spectrum of changes that affect morphology
and function of NAc excitatory circuits in cocaine–treated animals, impaired N-methyl-D-
aspartate receptor (NMDAR)-dependent synaptic plasticity is a typical feature. D-serine, a
D-amino acid that has been found at high levels in mammalian brain, binds with high affinity
the co-agonist site of NMDAR and mediates, along with glutamate, several important
processes including synaptic plasticity. Here we review recent literature focusing on
cocaine-induced impairment in synaptic plasticity mechanisms in the NAc and on the
fundamental role of D-serine as co-agonist of NMDAR in functional and dysfunctional
synaptic plasticity within this nucleus. The emerging picture is that reduced D-serine levels
play a crucial role in synaptic plasticity relevant to cocaine addiction. This finding opens new
perspectives for therapeutic approaches to treat this addictive state.
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INTRODUCTION
A large body of evidence has demonstrated the fundamental role
of D-serine as co-agonist at the N-methyl-D-aspartate recep-
tor (NMDAR), a major glutamate receptor subtype involved in
synaptic plasticity (Mothet et al., 2000; Panatier et al., 2006;
Fossat et al., 2012; Rosenberg et al., 2013). In particular, D-serine,
by binding the so called “glycine site” on the NR1 subunit, is
crucial for the activation of these receptors and for NMDAR-
dependent synaptic plasticity mechanisms. D-serine degradation
by the FAD-dependent enzyme D-amino acid oxidase (DAAO)
suppresses NMDAR-dependent component of excitatory synaptic
currents and prevents NMDAR-dependent long term potentia-
tion (LTP) and depression (LTD) in different brain areas, includ-
ing the hippocampus, the supraoptic nucleus and prefrontal
cortex (Yang et al., 2003; Panatier et al., 2006; Fossat et al.,
2012).
Abnormal levels of D-serine have been reported in aging
(Potier et al., 2010; Turpin et al., 2011; Haxaire et al., 2012; Billard,
2013), Alzheimer’s disease (Wu et al., 2004) and amyotrophic
lateral sclerosis (ALS; Sasabe et al., 2012; Paul and de Belleroche,
2014). Moreover, D-serine has emerged as an influential player
in the context of psychiatric diseases such as schizophrenia and
depression. Indeed, based on the rationale that a common feature
of these pathologies might be a dysregulation of glutamatergic
system, especially NMDAR-dependent synaptic transmission, an
increasing number of studies have investigated D-serine signaling
to explore possible causes and potential therapeutic interventions
for these diseases (Carlsson and Carlsson, 1990; Adage et al., 2008;
Lisman et al., 2008; Gunduz-Bruce, 2009; Hashimoto et al., 2009;
Labrie et al., 2012; Balu et al., 2013; Lane et al., 2013; Sacchi et al.,
2013).
More recently a link between D-serine signaling and cocaine
addiction, another neuropsychiatric disorder, has been proposed.
Cocaine addiction is a pathological learned behavior charac-
terized by compulsive drug seeking and high vulnerability to
relapse even after prolonged abstinence (Mendelson and Mello,
1996). A large body of evidence has linked the development
and expression of this addictive behavior to neuroadaptations in
the mesocorticolimbic system. The interconnected brain regions
that make up this system include the prefrontal cortex, the
ventral tegmental area, and the ventral striatum (also known as
nucleus accumbens, NAc), which has been critically implicated
in the expression of a variety of addiction-related behavioral
alterations (Koob and Volkow, 2010). In particular, cocaine-
induced neuroadaptations in the NAc have been associated
with changes in glutamatergic synaptic transmission and plas-
ticity (Kauer and Malenka, 2007; Lüscher and Malenka, 2011).
In this context, accumulating evidence indicates an impair-
ment of NMDAR-dependent LTP and LTD at glutamatergic
synapses in the NAc of animal models of cocaine addiction
(Martin et al., 2006; Moussawi et al., 2009; Kasanetz et al.,
2010).
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A link between D-serine and cocaine addiction was first indi-
cated by findings that D-serine reduced the expression of cocaine-
induced conditioned place preference (a standard behavioral
model used to study the rewarding and aversive effects of drugs)
(Yang et al., 2013), and that reduced cocaine-primed reinstate-
ment following extended access to cocaine self-administration
(Kelamangalath and Wagner, 2010). Within this context we have
recently addressed the issue of whether D-serine signaling could
be involved in cocaine-induced neuroadaptations in the NAc of a
rat model of non-contingent (passive) cocaine exposure (Curcio
et al., 2013).
D-SERINE-RELATED PATHWAY IN THE NAc
Since the initial detection of D-serine in the central nervous
system (Hashimoto and Oka, 1997) subsequent immunostaining
studies have more precisely localized D-serine, DAAO and serine
racemase (SR), the major biosynthetic enzyme for D-serine, in
mammalian brain (Williams et al., 2006; Verrall et al., 2007; Paul
and de Belleroche, 2014). SR was initially identified in astrocytes
and microglia (Wolosker et al., 1999; Stevens et al., 2003; Wu
et al., 2004; Panatier et al., 2006). More recently, however, SR was
also identified in neurons (Kartvelishvily et al., 2006; Dun et al.,
2008; Wolosker, 2011; Miya et al., 2008; Rosenberg et al., 2013;
Balu et al., 2014) challenging the classical view that D-serine is a
gliotransmitter.
In the NAc the presence of D-serine, DAAO and SR was
found in both neurons and astrocytes (Curcio et al., 2013). This
cellular localization in the NAc is consistent with the model of
D-serine dynamics proposed by Wolosker (2011) that is based
upon the notion that D-serine is primarily made in neurons
and explains why drugs blocking astrocyte metabolism affect
D-serine extracellular level (Zhang et al., 2008; Henneberger
et al., 2010). This so-called “serine shuttle model” proposes
that astrocytes synthesize and export L-serine to neurons to
fuel the synthesis of D-serine by the neuronal SR. Once syn-
thesized and released by neurons, D-serine can be taken up by
astrocytes for storage and activity-dependent release (Martineau
et al., 2013). Our results also showed that the intensity of
immunostaining for D-serine and its related enzymes among
labeled neuronal cells (>80% of NAc core neurons) was different,
likely reflecting different levels of expression. Considering that
there are two main types of MSNs: those expressing D1-like
receptors and those that express D2-like dopamine receptors
(Sesack et al., 1994; Hara and Pickel, 2005; D’Ascenzo et al.,
2009; Podda et al., 2010), and that these cell subtypes show
different responses to cocaine exposure (Lobo et al., 2010; Maze
et al., 2014), it would be of interest to establish whether these
two neuronal subtypes differentially express D-serine machin-
ery.
As in other brain areas, the presence of D-serine in the NAc
is related to its ability to act as NMDAR co-agonist at synaptic
level. Indeed, electrophysiological data provided by our group
showed a marked increase in AMPA/NMDA ratio at excitatory
synapses in brain slices where D-serine levels had been lowered
by incubation with RgDAAO. In contrast enzymatic degradation
of glycine with glycine oxidase did not affect AMPA/NMDA
ratio (Curcio et al., 2013). The same study also revealed the
essential role of D-serine in synaptic plasticity mechanisms
within the NAc by showing that enzymatic D-serine degrada-
tion prevented the induction of NMDAR-dependent LTP and
LTD.
REDUCED D-SERINE LEVELS IN A RAT MODEL OF
COCAINE-ADDICTION
Although our knowledge on the molecular mechanisms under-
lying the behavioral changes induced by cocaine abuse is far
from be complete, research on rodent models has successfully
identified alterations in NMDAR-dependent synaptic plasticity as
an important component of these behavioral changes.
Several studies have indeed demonstrated impairment of LTP
and LTD in different models of cocaine addiction. In vivo exper-
imental evidence showed that after long-term withdrawal from
cocaine self-administration LTP cannot be induced in the rat NAc
core (Moussawi et al., 2009). The impairment of LTP reported
in this study has been attributed to a pre-existing LTP-like state,
developed during cocaine treatment and/or withdrawal, in which
the synaptic strength is maximized. Moussawi et al. (2009) also
observed loss of LTD inducibility in the rat NAc after long-
term withdrawal from self-administered cocaine, an effect that
could not be explained by pre-existing synaptic potentiation.
Impairment of LTD has also been reported by other authors in
rats with a history of cocaine in both in vivo and ex vivo (i.e., brain
slices) preparations (Martin et al., 2006; Kasanetz et al., 2010). It
is well known that in many regions of the brain the induction of
both LTP and LTD is dependent on the activation of NMDARs
which leads to postsynaptic Ca2+ influx. LTP is mediated by
large, short-lived increases in the intracellular Ca2+ concentration
that is believed to occur following activation of synaptic NR2A-
containing NMDARs, whereas moderate Ca2+ increases through
extrasynaptic NR2B-containing NMDARs have been involved in
the induction of LTD (Massey et al., 2004; Yashiro and Philpot,
2008; Hunt and Castillo, 2012). Such different regulation of
intracellular Ca2+ levels are supposed to trigger different subset
of Ca2+-dependent intracellular signaling molecules required for
both forms of synaptic plasticity.
NMDAR hypofunction with reduced Ca2+ influx at the post-
synaptic level is an attractive hypothesis to explain the impair-
ment of both LTP and LTD in cocaine-treated animals.
In keeping with this, recent findings from our laboratory
have raised the intriguing possibility that cocaine treatment is
associated with changes in D-serine signaling, that contribute to
synaptic plasticity dysfunction (Figure 1). In slices from cocaine-
treated rats exposure to saturating levels of exogenous D-serine
fully restored LTP and LTD inducibility (Figure 1C). Moreover,
NMDAR neurotransmission driven by endogenous D-serine was
impaired in the NAc slices from cocaine-treated rats (Curcio et al.,
2013).
Further support to the involvement of NMDAR hypofunc-
tion in mediating changes in synaptic plasticity observed in our
cocaine treatment paradigm comes from data demonstrating
an increase in AMPA/NMDA ratio in cocaine-treated rats that
was not associated with changes in AMPA receptor function
and expression. Additionally, biochemical assays revealed that
D-serine levels in the NAc extract obtained from cocaine-treated
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FIGURE 1 | Cocaine-induced deficits in NMDAR-dependent synaptic
plasticity in the NAc result from reduced D-serine levels. Compared to
control animals (A) in cocaine-treated rats (B) reduced levels of D-serine at
glutamatergic synapses impinging on medium spiny neurons leads to
NMDAR hypofunction that, in turn, causes impairments of LTP and LTD
elicited by standard stimulation protocols. Dashed arrows in B indicate
reduced expression of the enzyme whereas thick arrows indicate increased
levels of the enzyme. Asc1, alanine-serine-cysteine-1 transporter-1. ASCT,
alanine/serine/cysteine/threonine transporter. (C) Time course of LTP and LTD
in NAc slices from saline- (control) and cocaine-treated rats. High frequency
stimulation (HFS) and medium frequency stimulation (MFS) inducing LTP (left)
and LTD (right), respectively, are impaired in slices from cocaine-treated rats,
but not when the medium is supplemented with D-serine (red, ** p < 0.001).
Data are adapted from Curcio et al. (2013).
rats were significantly lower than those found in extracts from
saline-treated rats.
The molecular determinants of D-serine synaptic turnover
affected by cocaine treatment has yet to be definitively identi-
fied. However, considering that DAAO expression was increased
in cocaine treated rats at both the transcriptional and post-
transcriptional levels, whereas SR expression was reduced only
at post-transcriptional level, it may be speculated that the main
contribution to cocaine-related decrease in D-serine content
arises from both increased degradation and decreased synthesis
(Figure 1B; Curcio et al., 2013).
Although molecular and functional data from our and other
studies established a clear link between impaired D-serine signal-
ing and altered LTP and LTD in the NAc, the understanding of
cocaine–induced neuroplasticity changes is a very complex and
debated issue since different neuroadaptive changes at molecular
and cellular levels can occur at the same time in the NAc (Nestler,
2005; Kreek et al., 2012). Furthermore, adding complexity to this
scenario, conflicting results have been reported depending on
the drug-exposure protocols (e.g., self-administration or passive),
animal models used and duration of withdrawal (e.g., short or
long-term) (Thomas et al., 2001; Kourrich et al., 2007; Bowers
et al., 2010; Wolf and Tseng, 2012; Ortinski et al., 2013).
REDUCED D-SERINE SIGNALING IN THE NAc AS
MOLECULAR CORRELATE FOR COCAINE-INDUCED
LOCOMOTOR SENSITIZATION
Locomotor sensitization (usually measured as increased locomo-
tor responses to repeated administration of cocaine) has been
related to impairment of synaptic plasticity in the NAc (Thomas
et al., 2001; Kalivas et al., 2009). Moreover, this behavioral
paradigm has provided a major impetus to explore the neuro-
plasticity that may occur during the transition from drug use
to addiction (Koob and Volkow, 2010) and several studies have
demonstrated the essential role played by the NAc in both the
induction and expression phases of this cocaine-induced behav-
ioral alteration (Kalivas et al., 2009).
By injecting D-serine directly into the NAc, we demon-
strated that this amino acid blocks the development of locomo-
tor sensitization to cocaine (Figure 2). These findings indicate
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FIGURE 2 | Intra-accumbens microinjection of D-serine blocks
locomotor sensitization, an hallmark behavioral feature associated
with chronic exposure to cocaine. (A) Analysis of locomotor activity
measured by using an open field apparatus showing the distance traveled
by different groups of rats treated with saline or cocaine (15 mg/kg,
intraperitoneal, i.p.) and receiving intra-accumbens D-serine
(0.4 µg/0.3 µl) or vehicle. When rats are intra-NAc microinjected with
D-serine prior to cocaine treatment (red), the development of cocaine
sensitization is blocked (i.e., the distance traveled on days 2–5 is not
significantly different from day 1). (B) A single intra-NAc injection of
D-serine at day 5 reverts the effect of cocaine on locomotor activity (days
1–4). (C) Summary of cocaine-induced D-serine signaling dysregulation in
the NAc and consequent functional alterations. Data are taken from
Curcio et al. (2013).
that cocaine-induced impairment of D-serine signaling may be
a molecular correlate for cocaine-induced behavioral sensitiza-
tion and strongly support the notion that NMDAR-associated
glycine recognition site plays an important role in the cocaine
induced behavioral changes. In keeping with this, it has been
reported that partial agonists at NMDAR glycine site have
beneficial effects in rescuing cocaine–induced behavioral alter-
ations (Khan and Shoaib, 1996; Huang et al., 2008; Thanos
et al., 2009; Nic Dhonnchadha et al., 2010; Torregrossa et al.,
2010). The finding that D-serine reverts both the cocaine-
induced synaptic plasticity impairment and locomotor sensi-
tization points to this amino acid as an attractive tool for
counteracting the behavioral changes induced by cocaine in
humans. However, in this respect it should be pointed out
that, although still under debate (D’Souza et al., 2013), the
use of long-term treatment with large doses of D-serine has
been reported to cause side-effects, especially the oxidation-
dependent necrosis of renal proximal tubules (Williams and
Lock, 2004; Krug et al., 2007). A possible strategy to over-
come potential side effects would be to employ low doses of
D-serine together with oral administration of DAAO inhibitors.
This therapy has been successfully used to reduce cognitive
symptoms in animal models of schizophrenia (Adage et al.,
2008; Ferraris et al., 2008; Hashimoto et al., 2009). Further-
more, a recent study showed that sodium benzoate, a DAAO
inhibitor, per se significantly improved a variety of symp-
tom domains and neurocognition in patients with chronic
schizophrenia (Lane et al., 2013). Taken together these findings
hold promise for treating cocaine addiction by targeting D-serine
signaling.
CONCLUSIONS
Cocaine is the second most commonly used illegal drug world-
wide after cannabis. Prevalence of cocaine use (last year, life-
time) is particularly high among aged between 15 and 34 years.
Cocaine addiction is a worldwide public health problem with
consequences beyond its somatic and psychiatric effects including
socio-economic and judicial complications. The number of long-
term cocaine-dependent patients entering drug treatment has
been increasing in Europe for several years. However, there is
no specific pharmacotherapy with established efficacy for the
treatment of cocaine addiction and basic research on this field
represents one of the most important tool to face and counteract
this important public health problem.
During the last 5 years data have accumulated assigning a
significant role to D-serine in mediating synaptic plasticity and
behavioral changes associated with cocaine addiction. These find-
ings encourage the development of new pharmacological inter-
ventions targeting D-serine signaling to treat addiction. However,
many questions still remain to be answered, especially those
regarding the synaptic turnover of this amino acid in the brain.
For example, what is the selective contribution of astrocytes
and neurons to D-serine release? Is D-serine released through
vesicular and/or nonvescicular mechanisms? How SR and DAAO
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expression and activity are regulated? The understanding of these
mechanisms is essential before considering the development of
D-serine-derived drugs for the treatment of cocaine addiction
and other psychiatric disorders or cognitive deficits associated to
impaired NMDAR-dependent synaptic plasticity.
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